OmniActive Health Technologies (OmniActive) has announced its receipt of Generally Recognized as Safe (GRAS) status for Gingever. The product is a high-potency ginger extract designed to help support digestive and immune health at a low dose. Obtaining GRAS status allows for more comprehensive product applications for the ingredient, namely foods and beverages.
“For an ingredient to be considered GRAS, scientific data and information about the intended use of the substance must be widely known, and there must be a consensus among scientific experts that the data and information established is safe under the conditions of its intended use,” said Dr. Deshanie Rai, VP, Global Scientific & Regulatory Affairs for OmniActive. “This includes toxicology studies as well as human safety data. Moreover, the extraction and processing of the substance are also critically reviewed as part of the rigorous GRAS evaluation process.”
The GRAS Panel comprises a group of subject matter experts qualified by training and experience to evaluate the safety of food ingredients. “Given the rigor of the review and the necessary documentation required for compiling a dossier, achieving GRAS status is a lengthy and resource-intensive process,” explained Dr. Rai. “Although ginger has a long history of safe use as part of our food supply, we went the extra mile to have the safety of our Gingever product, which is formulated using a supercritical CO2 extraction method, verified by independent expert scientists.”
Gingever applies supercritical CO2 extraction technology to concentrate the active compounds found in ginger without using harsh solvents. Additionally, the process provides a rich source of ginger’s polyphenols in a composition similar to that found naturally in ginger root. 20 mg – 250 mg of Gingever delivers a clinically relevant dose of active compounds in ginger in a tiny pill compared to 1000 mg of ginger root powder.
